BMC Neurology (Mar 2020)

Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies

  • Mark E. Bangs,
  • David Kudrow,
  • Shufang Wang,
  • Tina M. Oakes,
  • Gisela M. Terwindt,
  • Delphine Magis,
  • Laura Yunes-Medina,
  • Virginia L. Stauffer

DOI
https://doi.org/10.1186/s12883-020-01675-7
Journal volume & issue
Vol. 20, no. 1
pp. 1 – 2

Abstract

Read online

Following publication of the original article [1], the authors noticed an error in the values for ‘Hypersensitivity SMQ’ and ‘Rash’ in Table 7.